Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OMNICELL, INC. Director's Dealing 2020

Apr 3, 2020

31980_dirs_2020-04-03_b3ffe2e0-8e93-4bd3-b027-be340c83ab63.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2020-04-02

Reporting Person: LIPPS RANDALL A (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-02 Common Stock S 350 $60.6343 Disposed 269059 Indirect
2020-04-02 Common Stock S 2700 $62.7152 Disposed 266359 Indirect
2020-04-02 Common Stock S 1950 $63.6295 Disposed 264409 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 159266 Direct
Common Stock 269409 Indirect
Common Stock 8051 Indirect

Footnotes

F1: Shares held in trust with Mr. Lipps' wife.

F2: Shares held in trust for the benefit of Mr. Lipps' children.

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.

F4: The price reported in Column 4 is the average price of $60.6343. The sold price range between $60.28 to $60.76. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is the average price of $62.7152. The sold price range between $62.13 to $63.1250. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is the average price of $63.6295. The sold price range between $63.36 to $64.34. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: Due to an administrative error, the balance of shares held in trust for the benefit of Mr. Lipps' children were incorrectly reported in prior Form 4s as 7,776 shares; this balance has been adjusted to reflect the corrected balance of 8,051 shares.